GIP and diabetes mellitus: Since previous studies have shown that endogenous GIP is rapidly metabolized to GIP (3–42), which can act as a weak partial agonist at GIP receptors (48), it is possible that GIP (3–42) contributes to the beneficial metabolic effects observed after Gs-mediated stimulation of GIP release in this STZ diabetes model.